Peptic ulcer disease final

bimelk 24,069 views 53 slides Jul 06, 2014
Slide 1
Slide 1 of 53
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53

About This Presentation

No description available for this slideshow.


Slide Content

PEPTIC ULCER DISEASE

INTRODUCTION

PREVELENCE In India, the prevalence of peptic ulcers is estimated to be 4-10 per1000 population

INCIDENCE Age 30–60 Male: female–3:1

RISK FACTORS H. pylori, Alcohol, Smoking, Cirrhosis, Stress Usually 50 and over Male higher risk Normal ,hyper secretion of stomach acid ( HCl ) (zollinger Ellison syndrome) Gastritis, Use of NSAIDs

Types Acute Chronic

Acute Is associated with superficial erosion and minimal inflammation it is of short duration and resolves quickly when the cause is identified and removed

Chronic Chronic ulcer is one of long duration eroding through the muscular wall with the formation of fibrous tissue it may be present continuously for many months or intermittently throughout the person’s life time

Another classification Gastric duodenal

Comparison of gastric and deodenal ulcer

ETIOLOGY stress and anxiety gram-negative bacteria H. pylori Stress Excessesive secretion of HCL Familial tendency Blood group o Use of NSAID Alcohol Excessive smoking Hyperacidity Gastrin secreting malignant tumors Esophageal ulcers GERD

PATHOPHYSIOLOGY Peptic ulcer occurs mainly in the gastro duodenal mucosa because this tissue cannot withstand the digestive action of gastric acid HCl and pepsin. Vagus nerve stimulates the parietal cells to secrete gastric acid. The erosion is caused by the increased concentration or activity of pepsin, or by decreased resistance of the mucosa. A damaged mucosa cannot secrete enough mucus to act as a barrier against HCl . The use of NSAIDs inhibits the secretion of mucus that protects the mucosa .

CLINICAL MANIFESTATIONS dull, gnawing pain or a burning Pain is usually relieved by eating Tenderness pyrosis (heartburn), vomiting, constipation or diarrhea, and bleeding burping vomiting bleeding tarry stools

ASSESSMENT AND DIAGNOSTIC FINDINGS Pain, Epigastric tenderness, Abdominal distention . A barium study Stools study Gastric secretory studies H. Pylori infection Breath test that detects H. Pylori

MEDICAL MANAGEMENT Antibiotics Eradicate H. pylori Rest sedatives Tranquilizers Octreotide ( decrese gastric activity) cytoprotective agents ( sucralfate )

PHARMACOLOGIC THERAPY proton pump inhibitors antibiotics bismuth salts histamine 2 antagonist proton pump inhibitors

STRESS REDUCTION AND REST Avoid stressful or exhausting situations A rushed lifestyle irregular schedule Biofeed back Hipnosis Behavier modification Change in job

SMOKING CESSATION smoking decreases the secretion of bicarbonate from the pancreas into the duodenum resulting in increased acidity of the duodenum.

DIETARY MODIFICATION avoiding extremes of temperature Over stimulation from consumption of meat extracts alcohol, coffee (including decaffeinated coffee ) Milk cream

SURGICAL MANAGEMENT Principles of surgery Reduce acid secreting ability Remove malignant or potentially malignant lesions treat surgical emergency Treat clients do not respond to medical intervention

VAGOTOMY Vagotomy is performed to eliminate the acid secreting stimulus to gastric cells Truncal Completely cutting each vagus nerve Selective The surgeon partially severs the nerves to preserve the hepatic and celiac branches Proximal Only paritel cell mass is denerveted

Truncal

VAGOTOMY WITH PYLOROPLASTY

GASTROENTEROSTOMY Permits regurgitation of alkaline deodenal contents thereby neutralizing gastric acid in this procedure a drain is made on the bottom of the stomach and sewn to an opening made in the jejunum

ANTRECTOMY

SUBTOTAL GASTERCTOMY This is a genetic term referring to any surgery that involves partial removal of the stomach may be performed by either Billroth 1 or Billroth 2

BILLROTH GASTRECTOMY Operation was devised more by accident than a surgery design A gastro enterostomy was performed on a gravely ill patient with a pyloric resection by Christian Aiberl Theociot Billroth . 1829-1894, Professor of Surgery, Vienna, Austria. Anton wolfler . 1850-1917, Professor of Surgery, Prague, The Czech Republic further refined the surgery The first successful gastrectomy was performed by Billroth in January 1881, and Wolfler performed the first gastroenterostomy in the same year

BILROTH 1 The surgeon removes a part of distal portion of the stomach including the andrum the remainder of the stomach is anastomosed to duodenum this combined procedure called gastrodeodenostomy this decreases dumping syndrome

BILROTH 1

BILROTH II This involves reanastomosis of the proximal remnant of the stomach to the proximal jejunum pancreatic secretions and bile continue to secrete in jejunum even after surgery surgeons prefer Billroth 2 technique for treatment of duodenal ulcers because recurrent ulcer develops less frequent in this procedure

BILROTH II

COMPLICATIONS Dumping syndrome Early dumping Early dumping include abdominal and vasomotor symptoms which are found in 5-10%of patients the small bowel is filled with food from stomach which have high osmotic load this lead to shift of fluid to stomach from systemic circulation symptoms are vertigo, tachycardia syncope sweating pallor palpitation diarrhea and nausea etc

Late dumping This is reactive hypoglycemia . The carbohydrate load in the small bowel causes a rise in the plasma glucose level, which, in turn, causes insulin levels to rise, causing a secondary hypoglycemia. This can be easily demonstrated by serial measurements of blood glucose in a patient following a test meal. Other symptoms include epigastric fullness distention discomfort abdominal cramping nausea etc the treatment is essentially the same as for early dumping

TREATMENT The principal treatment is dietary manipulation, dry meals are best, and avoiding fluids with a high carbo­hydrate content

Other side effects Hemorrhage Marginal ulcers Alkaline reflex gastritis Nutritional deficiency ( Vitamin B12 and folic acid deficiency)

FOLLOW-UP CARE The likelihood of recurrence is reduced if the patient avoids smoking, coffee (including decaffeinated coffee) and their caffeinated beverages, alcohol, and ulcerogenic medications ( eg , NSAIDs)

NURSING PROCESS: Assessment Pain, (type timing, duration) Use of antacids Vomitus Smoking Use of alcohol Use of NSAID Eating habbits , Blood in stool Physical examination

NURSING DIAGNOSES Acute pain related to incresed gastric secretions , decresed mucosal protection ,and ingestion of gastric irritants as evidenced by burning cramp like pain in epigastrium and abdomen Nausea related to acute exacerbation of disease process as evidenced by episodes of nausea and vomiting Ineffective therapeutic regimen management related to lack of knowledge of long term management of peptic ulcer disease and consequence of not following treatment plan and unwillingness to modify lifestyle as evidenced by frequent questions about home care incorrect response to questions about peptic ulcer disease

NURSING INTERVENTIONS RELIEVING PAIN REDUCING ANXIETY MAINTAINING OPTIMAL NUTRITIONAL STATUS MAINTAINING OPTIMAL NUTRITIONAL STATUS TEACHING PATIENTS SELF-CARE

RELIEVING PAIN Pain relief can be achieved with prescribed medications . The patients hould avoid aspirin, foods and beverages that contain caffeine, and decaffeinated coffee, meals should be eaten at regularly paced intervals in a relaxed setting. Some patients benefit from learning relaxation techniques to help manage stress and pain and to enhance smoking cessation efforts

REDUCING ANXIETY The nurse assesses the patient’s level of anxiety . Patients with peptic ulcers are usually anxious, but their anxiety is not always obvious. Appropriate information is provided at the patient’s level of understanding, all questions are answered, and the patient is encouraged to express fears openly . Explaining diagnostic tests and administering medications on schedule also help to reduce anxiety . The nurse interacts with the patient in a relaxed manner, helps identify stressors, and explains various coping techniques and relaxation methods, such as biofeedback, hypnosis, or behavior modification. The patient’s family is also encouraged to participate in care and to provide emotional support.

MAINTAINING OPTIMAL NUTRITIONAL STATUS assesses the patient for malnutrition and weight loss. After recovery from an acute phase of peptic ulcer disease, the patients are advised about the importance of complying with the medication regimen and dietary restrictions.

TEACHING PATIENTS SELF-CARE Give information about medications to be taken at home, including name, dosage, frequency, and possible side effects, stressing the importance of continuing to take medications even after signs and symptoms have decreased or subsided. the patient is instructed to avoid certain medications and foods that exacerbate symptoms as well as substances that have acid producing potential ( eg , alcohol; caffeinated beverages such as coffee, tea, and colas). It is important to counsel the patient to eat meals at regular times and in a relaxed setting, and to avoid overeating the nurse also informs the patient about the irritant effects of smoking on the ulcer and provides information about smoking cessation programs. The nurse reinforces the importance of follow-up care for approximately1 year, the need to report recurrence of symptoms , and the need for treating possible problems that occur after surgery, such as intolerance to dairy products and sweet foods

POTENTIAL COMPLICATIONS Hemorrhage Perforation and Penetration Pyloric Obstruction

Hemorrhage Monitoring the hemoglobin and hematocrit to assist in evaluating blood loss Inserting an NG tube to distinguish fresh blood from “coffee grounds” material, to aid in the removal of clots and acid, to prevent nausea and vomiting, and to provide a means monitoring further bleeding Administering a room-temperature lavage of saline solution or water. This is controversial; some authorities recommend using ice lavage Inserting an indwelling urinary catheter and monitoring urinary output Monitoring vital signs and oxygen saturation and administering oxygen therapy Placing the patient in the recumbent position with the legs elevated to prevent hypotension; or, to prevent aspiration from vomiting, placing the patient on the left side Treating hemorrhagic shock

Perforation and Penetration Hypotension and tachycardia, indicating shock Because chemical peritonitis develops within a few hours after perforation and is followed by bacterial peritonitis , the perforationmust be closed as quickly as possible and assesses the patient for peritonitis or localized infection (increased temperature, abdominal pain, paralytic ileus, increased or absent bowel sounds, abdominal distention). Antibiotic therapy is administered parenteral as prescribed Immediate surgical repair and haemodynamic stabilisation

Pyloric Obstruction insert an NG tube to decompress the stomach. Confirmation that obstruction is the cause of the discomfort is accomplished by assessing the amount of fluid aspirated from the NG tube . A residual of more than 400 mL strongly suggests obstruction . Usually an upper GI study or endoscopy is performed to confirm gastric outlet obstruction. Decompression of the stomach and management of extracellular fluid volume and electrolyte balances may improve the patient’s condition and avert the need for surgical intervention . A balloon dilatation of the pylorus via endoscopy may be beneficial . If the obstruction is unrelieved by medical management, surgery (in the form of a vagotomy andantrectomy or gastrojejunostomy and vagotomy ) may be required.

FOLLOW-UP CARE Recurrence within 1 year may be prevented with the prophylactic use of H2 receptor antagonists given at a reduced dose. all patients require maintenance therapy; it may be prescribed only for those with two or three recurrences per year, The likelihood of recurrence is reduced if the patient avoids smoking, coffee (including decaffeinated coffee) and their caffeinated beverages, alcohol, and ulcerogenic medications ( eg , NSAIDs) etc

  Evidence based practice Conclusion

Bibliography

Thank you
Tags